About Yseop
Yseop is a company based in New York (United States) founded in 2008 by Alain Kaeser. Yseop has raised $9.3 million across 2 funding rounds from investors including Lilly, Novartis and NextStage AM. Yseop offers products and services including Yseop Copilot. Yseop operates in a competitive market with competitors including Eigen Technologies, Culture Biosciences, Traydstream, Author-it Software and Alkymi, among others.
- Headquarter New York, United States
- Founders Alain Kaeser
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$9.3 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
Lilly
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Yseop
Yseop offers a comprehensive portfolio of products and services, including Yseop Copilot.
Platform for automating regulatory and medical writing tasks
People of Yseop
Unlock access to complete
Funding Insights of Yseop
Yseop has successfully raised a total of $9.3M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Yseop
Yseop has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Lilly, Novartis and NextStage AM.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
NextStage AM is recognized as a pioneer in capital development.
|
Locked | Locked | Locked | |
|
Investments are made in real estate, digital media, and tech.
|
Locked | Locked | Locked | |
|
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
Locked | Locked | Locked |
Investor details for Yseop
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Yseop
Investment portfolio details for Yseop
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Yseop
Detailed financials for Yseop
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Yseop Comparisons
Peer comparison for Yseop
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Yseop
Yseop operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eigen Technologies, Culture Biosciences, Traydstream, Author-it Software and Alkymi, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI solutions for data extraction from documents are provided.
|
|
| Locked | Locked | Locked |
Biomanufacturing hardware and software tools are provided for research purposes.
|
|
| Locked | Locked | Locked |
Trade finance document processing solution
|
|
| Locked | Locked | Locked |
Enterprise authoring, content management & publishing platforms
|
|
| Locked | Locked | Locked |
Enterprise data digitization and analytics solutions are developed.
|
Detailed competitors of Yseop
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Yseop
Complete news archive for Yseop
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yseop
Yseop was founded in 2008 and raised its 1st funding round 10 years after it was founded.
Yseop is headquartered in New York, United States. It is registered at New York, New York, United States.
Emmanuel Walckenaer is the current CEO of Yseop.
Yseop is a funded company, having raised a total of $9.3M across 2 funding rounds to date.
Provider of automated natural language generation software for regulatory writing. The software streamlines document creation, ensures compliance, and accelerates submission timelines. It automates core reporting tasks, reduces drafting time, and enhances team collaboration. The platform integrates regulatory standards directly into document creation, automating compliance checks and minimizing risk.
Yseop's top competitors include Eigen Technologies, Culture Biosciences and Alkymi.
Yseop offers Yseop Copilot.
Yseop has 4 investors. Key investors include Lilly, Novartis, NextStage AM, and Wille Finance.